GDF2 and pulmonary arterial hypertension: That said, as compared to accepted features of HHT associated with mutations in these other three genes, individuals described to date with mutations in GDF2 have a distinctly different appearance and pattern to their cutaneous telangiectases, a presentation of PAVMs noteworthy for being tiny but diffuse, and are relatively more likely to have PAH.